153 related articles for article (PubMed ID: 37100231)
1. Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study.
Palmiero G; Cesaro A; Galiero R; Loffredo G; Caturano A; Vetrano E; Rinaldi L; Salvatore T; Ruggiero R; Rosaria Di Palo M; Sardu C; Marfella R; Limongelli G; Calabrò P; Carlo Sasso F
Diabetes Res Clin Pract; 2023 Jun; 200():110686. PubMed ID: 37100231
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN-HF study.
Correale M; Antohi EL; Inciardi RM; Mazzeo P; Coiro S; Ishihara S; Petroni R; Monitillo F; Leone M; Triggiani M; Sarwar CMS; Dungen HD; Talha KM; Brunetti ND; Butler J; Nodari S;
ESC Heart Fail; 2023 Jun; 10(3):2066-2073. PubMed ID: 36924023
[TBL] [Abstract][Full Text] [Related]
3. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).
Lee MMY; Brooksbank KJM; Wetherall K; Mangion K; Roditi G; Campbell RT; Berry C; Chong V; Coyle L; Docherty KF; Dreisbach JG; Labinjoh C; Lang NN; Lennie V; McConnachie A; Murphy CL; Petrie CJ; Petrie JR; Speirits IA; Sourbron S; Welsh P; Woodward R; Radjenovic A; Mark PB; McMurray JJV; Jhund PS; Petrie MC; Sattar N
Circulation; 2021 Feb; 143(6):516-525. PubMed ID: 33186500
[TBL] [Abstract][Full Text] [Related]
4. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.
Guazzi M; Bandera F; Pelissero G; Castelvecchio S; Menicanti L; Ghio S; Temporelli PL; Arena R
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1373-81. PubMed ID: 23997100
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
[TBL] [Abstract][Full Text] [Related]
6. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
Legris V; Thibault B; Dupuis J; White M; Asgar AW; Fortier A; Pitre C; Bouabdallaoui N; Henri C; O'Meara E; Ducharme A;
ESC Heart Fail; 2022 Feb; 9(1):450-464. PubMed ID: 34953062
[TBL] [Abstract][Full Text] [Related]
7. Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.
Ikonomidis I; Pavlidis G; Thymis J; Birba D; Kalogeris A; Kousathana F; Kountouri A; Balampanis K; Parissis J; Andreadou I; Katogiannis K; Dimitriadis G; Bamias A; Iliodromitis E; Lambadiari V
J Am Heart Assoc; 2020 May; 9(9):e015716. PubMed ID: 32326806
[TBL] [Abstract][Full Text] [Related]
8. Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction.
Çamcı S; Yılmaz E
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013595
[TBL] [Abstract][Full Text] [Related]
9. Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure.
Tanaka H; Soga F; Tatsumi K; Mochizuki Y; Sano H; Toki H; Matsumoto K; Shite J; Takaoka H; Doi T; Hirata KI
Cardiovasc Diabetol; 2020 Jan; 19(1):6. PubMed ID: 31910853
[TBL] [Abstract][Full Text] [Related]
10. Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence.
Natali A; Nesti L; Tricò D; Ferrannini E
Cardiovasc Diabetol; 2021 Sep; 20(1):196. PubMed ID: 34583699
[TBL] [Abstract][Full Text] [Related]
11. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation.
Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K
Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195
[TBL] [Abstract][Full Text] [Related]
12. Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial.
Omar M; Jensen J; Ali M; Frederiksen PH; Kistorp C; Videbæk L; Poulsen MK; Tuxen CD; Möller S; Gustafsson F; Køber L; Schou M; Møller JE
JAMA Cardiol; 2021 Jul; 6(7):836-840. PubMed ID: 33404637
[TBL] [Abstract][Full Text] [Related]
13. Left atrial strain predicts exercise capacity in heart failure independently of left ventricular ejection fraction.
Maffeis C; Rossi A; Cannata L; Zocco C; Belyavskiy E; Radhakrishnan AK; Feuerstein A; Morris DA; Pieske-Kraigher E; Pieske B; Edelmann F; Temporelli PL
ESC Heart Fail; 2022 Apr; 9(2):842-852. PubMed ID: 34989138
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus.
Song XT; Wei YL; Rui YF; Fan L
J Diabetes Complications; 2023 Jul; 37(7):108509. PubMed ID: 37235925
[TBL] [Abstract][Full Text] [Related]
15. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
[TBL] [Abstract][Full Text] [Related]
16. Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function.
Katogiannis K; Thymis J; Kousathana F; Pavlidis G; Korakas E; Kountouri A; Balampanis K; Prentza V; Kostelli G; Michalopoulou H; Tsilivarakis D; Lambadiari V; Ikonomidis I
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541121
[No Abstract] [Full Text] [Related]
17. Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis.
Zhang DP; Xu L; Wang LF; Wang HJ; Jiang F
Cardiovasc Diabetol; 2020 Jan; 19(1):10. PubMed ID: 31969144
[TBL] [Abstract][Full Text] [Related]
18. Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure.
Naseem M; Alkassas A; Alaarag A
BMC Cardiovasc Disord; 2022 Sep; 22(1):414. PubMed ID: 36115949
[TBL] [Abstract][Full Text] [Related]
19. Right ventricular-arterial coupling - A new perspective for right ventricle evaluation in heart failure patients undergoing cardiac resynchronization therapy.
Deaconu S; Deaconu A; Scarlatescu A; Petre I; Onciul S; Vijiac A; Onut R; Zamfir D; Marascu G; Iorgulescu C; Radu DA; Bogdan S; Vatasescu R; Dorobantu M
Echocardiography; 2021 Jul; 38(7):1157-1164. PubMed ID: 34028880
[TBL] [Abstract][Full Text] [Related]
20. Sodium glucose cotransporter-2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function.
Chan YH; Hsu TJ; Wang CL; Kao YW; Huang CY; Chu PH
ESC Heart Fail; 2020 Oct; 7(5):2784-2796. PubMed ID: 32627380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
